These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 10910807)
21. Aggression, agitation, and mania with olanzapine. John V; Rapp M; Pies R Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577 [No Abstract] [Full Text] [Related]
22. Plasma levels of cytokines and soluble cytokine receptors during treatment with olanzapine. Schuld A; Kraus T; Haack M; Hinze-Selch D; Kühn M; Pollmächer T Schizophr Res; 2000 Jun; 43(2-3):164-6. PubMed ID: 11001592 [No Abstract] [Full Text] [Related]
23. Worsening of obsessive-compulsive symptoms following treatment with olanzapine. Morrison D; Clark D; Goldfarb E; McCoy L Am J Psychiatry; 1998 Jun; 155(6):855. PubMed ID: 9619164 [No Abstract] [Full Text] [Related]
26. High-dose olanzapine for treatment-refractory schizophrenia. Sheitman BB; Lindgren JC; Early J; Sved M Am J Psychiatry; 1997 Nov; 154(11):1626. PubMed ID: 9356581 [No Abstract] [Full Text] [Related]
27. Healthy outcome under olanzapine treatment in a pregnant woman. Kirchheiner J; Berghöfer A; Bolk-Weischedel D Pharmacopsychiatry; 2000 Mar; 33(2):78-80. PubMed ID: 10761825 [TBL] [Abstract][Full Text] [Related]
28. Weight change and atypical antipsychotic treatment in patients with schizophrenia. Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752 [TBL] [Abstract][Full Text] [Related]
29. [Schizophrenia and depression. Special aspects in the therapy of women]. Nervenarzt; 1998 Jul; 69(7 Suppl Besondere):1-8. PubMed ID: 9713002 [No Abstract] [Full Text] [Related]
30. Reduction of tardive dystonia with olanzapine. Jaffe ME; Simpson GM Am J Psychiatry; 1999 Dec; 156(12):2016. PubMed ID: 10588425 [No Abstract] [Full Text] [Related]
31. Olanzapine use in women with antipsychotic-induced hyperprolactinemia. Canuso CM; Hanau M; Jhamb KK; Green AI Am J Psychiatry; 1998 Oct; 155(10):1458. PubMed ID: 9766782 [No Abstract] [Full Text] [Related]
32. Nonalcoholic steatohepatitis: a possible side effect of atypical antipsychotics. Haberfellner EM; Honsig T J Clin Psychiatry; 2003 Jul; 64(7):851. PubMed ID: 12934993 [No Abstract] [Full Text] [Related]
33. Adverse events related to olanzapine. Conley RR; Meltzer HY J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240 [TBL] [Abstract][Full Text] [Related]
34. New drug seen as breakthrough in treatment of schizophrenia. Ir Med J; 1996; 89(4):136. PubMed ID: 8824034 [No Abstract] [Full Text] [Related]
35. [Olanzapine--a new atypical neuroleptic. A chance for advancement in the therapy of schizophrenia]. Nervenarzt; 1997 Jul; 68(7 Suppl Olanzapin):1-8. PubMed ID: 9431360 [No Abstract] [Full Text] [Related]
36. Olanzapine: a new typical antipsychotic drug. Meltzer HY; Fibiger HC Neuropsychopharmacology; 1996 Feb; 14(2):83-5. PubMed ID: 8822530 [No Abstract] [Full Text] [Related]
37. [A case of leukopenia in treatment with risperidone in an adolescent]. Etain B; Roubaud L; Le Heuzey MF; Mouren Simeoni MC Encephale; 2000; 26(5):81-4. PubMed ID: 11192809 [TBL] [Abstract][Full Text] [Related]